Correction for presbyopia in cataract patients is a significant challenge for ophthalmologists and cataract surgeons, however, an increasingly diverse array of intraocular lenses (IOLs) that are capable of providing good quality near vision is available. Currently available synthetic lenses use different technologies to correct for presbyopia. The latest iterations of the AcrySof® ReSTOR® IOLs combine an optic with a central apodized diffractive zone, a peripheral refractive zone, an aspheric anterior to combat corneal aberrations, and an ultraviolet (UV)- and blue-light filtering chromophore. The AcrySof® IQ ReSTOR® IOLs provide excellent near vision restoration with increased spectacle independence and minimal severe side effects. As a result, it may represent a significant advance over other presbyopia-correcting technologies. IOLs such as the AcrySof® IQ ReSTOR® are increasingly replicating the full visual capabilities of the crystalline lens and are an important advancement in the treatment of presbyopia in cataract patients.
In vitro and in vivo assessment of biocompatibility of AZ31 alloy as biliary stents: a preclinical approach
